NPAS3-IN-1

CAS No. 2207-44-5

NPAS3-IN-1( —— )

Catalog No. M37303 CAS No. 2207-44-5

NPAS3-IN-1 is a potent inhibitor of NPAS3-ARNT heterodimerization, modulating NPAS3 transcription by targeting the interaction between NPAS3 and ARNT at the cellular level.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 116 Get Quote
5MG 179 Get Quote
10MG 282 Get Quote
25MG 477 Get Quote
50MG 679 Get Quote
100MG 888 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NPAS3-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    NPAS3-IN-1 is a potent inhibitor of NPAS3-ARNT heterodimerization, modulating NPAS3 transcription by targeting the interaction between NPAS3 and ARNT at the cellular level.
  • Description
    NPAS3-IN-1 is a potent inhibitor of NPAS3-ARNT heterodimerization and regulates NPAS3 transcription by disrupting the heterodimerization of NPAS3 with ARNT at the cellular level.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2207-44-5
  • Formula Weight
    295.36
  • Molecular Formula
    C10H5N3O2S3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (84.64 mM; Ultrasonic )
  • SMILES
    O=[N+]([O-])C1=CN=C(SC2=NC3=C(S2)C=CC=C3)S1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Li P, et al. Discovery of a highly potent NPAS3 heterodimer inhibitor by covalently modifying ARNT. Bioorg Chem. 2023 Oct;139:106676.?
molnova catalog
related products
  • Isophorone

    Isophorone (355-trimethyl-2-cyclohexen-1-one) a monoterpene and the structurally related 18-cineole and camphor have demonstrated a protective effect against cancer biological activity against a variety of microorganisms and anti-oxidant properties.

  • NMDAR antagonist 1

    NMDAR antagonist 1 is a potent and orally bioavailable NR2B-selective antagonist of NMDAR.

  • Nemorubicin

    Nemorubicin is a doxorubicin derivative that differs significantly from its parent drug in terms of spectrum of antitumor activity, metabolism and toxicity profile.?